| abstract |
Based on ligands with substituted pyridyl and imidazolyl groups, heterocyclic radionuclide complexes are prepared. The ligand is bifunctional and has an amino acid residue that can act as a linker to the bioactive molecule and a tridentate chelator that can complex the radionuclide. The bioactive molecule may be a peptide or somatostatin. [Selection] Figure 1 |